Brighthouse Financial (BHFAN) Financials
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BHFAN SEC filings page.
Brighthouse Financial, Inc. (BHFAN) reported $5.7B in revenue over the twelve months to Sep 30, 2026, down 9.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The liability-heavy balance sheet supports sharp revenue growth, but earnings expanded slowly and cash conversion remains incomplete.
FY2025 operating cash flow moved from-$290M in FY2024 to$259M , showing a meaningful cash-generation shift. Against FY2025 net income of$433M , the 59.8% conversion ratio indicates profit was translating into cash again, but not one-for-one.
Revenue grew
Liabilities represented
Financial Health Signals
Scored against insurers for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Brighthouse Financial, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Loss Ratio measures the claims an insurer paid out against the premiums it earned, so a lower ratio leaves more of every premium dollar with the company. Brighthouse Financial, Inc. scores 4/100 on it among other insurers.
Not available for Brighthouse Financial, Inc., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Brighthouse Financial, Inc. funded 2.8% of its assets with shareholders' equity at the end of fiscal year 2025, holding $6.8B of equity against $241.8B of assets. Capital ranks insurers on that cushion, and Brighthouse Financial, Inc. scores 5/100 among other insurers.
Not available for Brighthouse Financial, Inc., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Combined Ratio puts claims and running costs together against premiums earned, and a figure under 100% means the underwriting made money before any investment income was counted. Brighthouse Financial, Inc. scores 4/100 on it among other insurers.
Brighthouse Financial, Inc. reported net income of $433.0M in fiscal year 2025, against $388.0M in fiscal year 2024. Stability ranks insurers on how steady net income has been across five years, and Brighthouse Financial, Inc. scores 16/100 among other insurers.
Brighthouse Financial, Inc. passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
Key Financial Metrics
Earnings & Revenue
Brighthouse Financial, Inc. generated $853.0M in revenue in Q3 2026. This represents a decrease of 53.0% from the same quarter a year earlier. Against the prior quarter it is down 47.4%.
Brighthouse Financial, Inc. reported $328.0M in net income in Q3 2026. This represents a decrease of 31.5% from the same quarter a year earlier. Against the prior quarter it is down 66.6%.
Brighthouse Financial, Inc. earned $5.21 per diluted share (EPS) in Q3 2026. This represents a decrease of 34.0% from the same quarter a year earlier. Against the prior quarter it is down 68.5%.
Not reported for Q3 2026.
Cash & Balance Sheet
Brighthouse Financial, Inc. held $8.5B in cash against $3.2B in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Brighthouse Financial, Inc.'s net profit margin was 38.5% in Q3 2026, showing the share of revenue converted to profit. This is up 12.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 22.0 percentage points.
Brighthouse Financial, Inc.'s quarterly ROE was 6.6% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 8.4 percentage points.
Not reported for Q3 2026.
Not reported for Q3 2026.
Capital Allocation
Brighthouse Financial, Inc. repurchased no shares in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q3 2026.
Not reported for Q3 2026.
BHFAN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $853.0M-53.0% | $1.6B+86.2% | $1.5B-36.1% | $1.7B+40.2% | $1.8B-10.0% | $871.0M-39.0% | $2.4B+3129.7% | $1.2B-13.9% |
| Interest Expense | $38.0M0.0% | $38.0M0.0% | $38.0M0.0% | $38.0M0.0% | $38.0M0.0% | $38.0M0.0% | $38.0M0.0% | $38.0M |
| Income Tax | $74.0M-28.8% | $245.0M+2962.5% | -$222.0Mn/m | $12.0M-92.6% | $104.0M+940.0% | $8.0Mn/m | -$88.0Mn/m | $162.0M |
| Net Income | $328.0M-31.5% | $981.0M+1054.1% | -$766.0Mn/m | $137.0M-79.6% | $479.0M+172.2% | $85.0M+150.0% | -$268.0Mn/m | $671.0Mn/m |
| EPS (Basic) | $5.24-33.9% | $16.62+1513.6% | -$13.82n/m | $1.95-81.4% | $7.93+218.5% | $1.03 | -$5.04n/m | $10.49n/m |
| EPS (Diluted) | $5.21-34.0% | $16.53+1520.6% | -$13.82n/m | $1.93-81.5% | $7.89+219.4% | $1.02 | -$5.04n/m | $10.46n/m |
| Diluted Shares (Avg) | 58M+0.6% | 58M+0.2% | 57M-1.6% | N/A | 58M-5.6% | 58M | 58M-7.6% | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.
BHFAN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $238.7B-2.5% | $247.2B+1.9% | $236.8B+0.9% | $241.8B+1.4% | $244.7B-0.2% | $242.6B+2.2% | $234.7B-2.1% | $238.5B+0.9% |
| Cash & Equivalents | $8.5B+29.1% | $7.1B+28.2% | $4.9B+5.1% | $5.4B+6.8% | $6.6B+17.3% | $5.5B+24.7% | $4.7B+22.1% | $5.0B+31.0% |
| Short-Term Investments | $626.0M-19.5% | $960.0M-17.9% | $1.2B-21.2% | $1.2B-35.9% | $778.0M-57.1% | $1.2B-15.8% | $1.6B+16.5% | $1.9B+59.8% |
| Total Liabilities | $233.6B-2.0% | $240.6B+1.5% | $231.2B+0.8% | $235.0B+0.6% | $238.3B-0.5% | $236.9B+1.6% | $229.4B-2.6% | $233.5B+0.9% |
| Long-Term Debt | $3.2B-0.1% | $3.2B0.0% | $3.2B0.0% | $3.2B0.0% | $3.2B0.0% | $3.2B0.0% | $3.2B0.0% | $3.2B0.0% |
| Total Equity | $5.0B-21.2% | $6.5B+15.5% | $5.6B+6.2% | $6.8B+36.5% | $6.4B+15.2% | $5.7B+37.0% | $5.2B+24.9% | $5.0B+0.3% |
| Retained Earnings | -$143.0Mn/m | -$471.0Mn/m | -$1.5Bn/m | -$686.0Mn/m | -$823.0Mn/m | -$1.3Bn/m | -$1.4Bn/m | -$1.1Bn/m |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.
BHFAN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$476.0M-506.8% | -$431.0Mn/m | -$221.0M-251.4% | -$3.0Mn/m | $117.0M+387.5% | -$1.0M-100.3% | $146.0Mn/m | -$118.0M-177.6% |
| Investing Cash Flow | $650.0M-52.6% | -$97.0M-186.6% | -$485.0M-186.1% | -$1.3Bn/m | $1.4Bn/m | $112.0Mn/m | $563.0Mn/m | -$357.0Mn/m |
| Financing Cash Flow | $1.2Bn/m | $2.7B+257.7% | $226.0Mn/m | $80.0Mn/m | -$423.0M-132.7% | $762.0M-44.2% | -$1.1B-196.5% | -$110.0M-126.7% |
| Share Buybacks | $0n/m | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% | $43.0M-32.8% | $59.0M-4.8% | $60.0M0.0% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid.
BHFAN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Net Margin | 38.5%+12.1pp | 60.5%+50.7pp | -50.2%-39.0pp | 8.1%-47.6pp | 26.4%+17.7pp | 9.8%+7.4pp | -11.2% | 55.7%+121.2pp |
| Return on Equity | 6.6%-1.0pp | 15.0%+13.5pp | -13.8%-8.6pp | 2.0%-11.5pp | 7.5%+4.3pp | 1.5%+0.7pp | -5.1%+6.6pp | 13.5%+32.1pp |
| Return on Assets | 0.1%-0.1pp | 0.4%+0.4pp | -0.3%-0.2pp | 0.1%-0.2pp | 0.2%+0.1pp | 0.0%0.0pp | -0.1%+0.1pp | 0.3%+0.7pp |
| Debt-to-Equity | 0.63+0.1x | 0.48-0.1x | 0.570.0x | 0.47-0.2x | 0.50-0.1x | 0.56-0.2x | 0.60-0.1x | 0.640.0x |
| Liabilities-to-Equity | 46.61+9.2x | 36.73-5.0x | 41.56-2.2x | 34.72-12.4x | 37.44-5.9x | 41.76-14.6x | 43.78-12.3x | 47.09+0.3x |
| Asset Turnover | 0.000.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.000.0x | 0.010.0x | 0.010.0x |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Brighthouse Financial, Inc. BHFAN | FY2025 | $6.8B | $433.0M | 6.4% | N/A | 7/100 |
| Manulife Financial Corp. MFC | FY2025 | $44.5B | $4.1B | 9.1% | $72.7B | 29/100 |
| MetLife, Inc. MET | FY2025 | $77.1B | $3.4B | 4.4% | $63.0B | 29/100 |
| Aflac Inc. AFL | FY2025 | $17.2B | $3.6B | 21.2% | $62.6B | 73/100 |
| Prudential Financial, Inc. PRU | FY2025 | $60.8B | $3.6B | 5.9% | $42.0B | 18/100 |
| Prudential plc PUK | FY2025 | $11.5B | $4.0B | 34.6% | $30.8B | 15/100 |
Where Brighthouse Financial, Inc. Ranks
Frequently Asked Questions
Brighthouse Financial, Inc. (BHFAN) reported $6.8B in total revenue for fiscal year 2025. This represents a 43.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Brighthouse Financial, Inc. (BHFAN) revenue grew by 43.2% year-over-year, from $4.7B to $6.8B in fiscal year 2025.
Yes, Brighthouse Financial, Inc. (BHFAN) reported a net income of $680.0M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $433.0M, with a net profit margin of 6.4%.
As of fiscal year 2025, Brighthouse Financial, Inc. (BHFAN) had $5.4B in cash and equivalents against $3.2B in long-term debt.
Brighthouse Financial, Inc. (BHFAN) had a net profit margin of 6.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Brighthouse Financial, Inc. (BHFAN) has a return on equity of 6.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Brighthouse Financial, Inc. (BHFAN) generated $259.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Brighthouse Financial, Inc. (BHFAN) had $241.8B in total assets as of fiscal year 2025, including both current and long-term assets.
Brighthouse Financial, Inc. (BHFAN) had a debt-to-equity ratio of 0.47 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Brighthouse Financial, Inc. (BHFAN) had a liabilities-to-equity ratio of 34.72 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Brighthouse Financial, Inc. (BHFAN) had a return on assets of 0.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Brighthouse Financial, Inc. (BHFAN) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Brighthouse Financial, Inc. (BHFAN) scores 7 out of 100 on our Financial Health Score, indicating weak standing within its insurers peer group. The score is the average of six dimensions (Loss Ratio, Premium Growth, Capital, Investment Yield, Combined Ratio, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Brighthouse Financial, Inc. it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.